We are also unable to assess insulin autoimmunity in our cohort as all participants were insulin treated, meaning we would be unable to distinguish between insulin autoantibodies (IAA) recognising exogenous insulin (immunity) and IAA to endogenous insulin (autoimmunity) [13, 14]. The gene discussed is INS; the disease is Autoimmunity.